TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06302348: A Study of Sepiapterin in Participants With Phenylketonuria (PKU)

Sponsor: PTC Therapeutics · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 56 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$2,592,920

Rescue Site Savings

+$1,697,184

Unlock Full NCT06302348 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06302348 Rescue Dossier →